These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 4342776

  • 1. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
    Radom S, Zulawski M, Golebiowska D.
    Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776
    [No Abstract] [Full Text] [Related]

  • 2. [Urine hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in neoplastic diseases].
    Radom S, Zulawski M, Golebiowska D.
    Nowotwory; 1971; 21(4):267-73. PubMed ID: 5138713
    [No Abstract] [Full Text] [Related]

  • 3. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
    Stĕpán JJ, Mikulecký M, Bek V, Broulík P, Pacovský V.
    Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
    [Abstract] [Full Text] [Related]

  • 4. Bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in thyrotoxicosis.
    Broulik PD, Stĕpán JJ, Límanová Z, Pacovský V.
    Endocrinol Exp; 1985 Sep; 19(3):165-9. PubMed ID: 3876205
    [Abstract] [Full Text] [Related]

  • 5. Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
    Lee CA, Lloyd HM.
    Cancer; 1971 May; 27(5):1099-105. PubMed ID: 5092517
    [No Abstract] [Full Text] [Related]

  • 6. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
    Matsushita Y, Hasegawa K, Sugimura R, Otomo S, Morii H.
    Endocrinol Jpn; 1974 Apr; 21(2):109-13. PubMed ID: 4408206
    [No Abstract] [Full Text] [Related]

  • 7. Hydroxyproline excretion in malignant neoplastic disease.
    Hosley HF, Taft EG, Olson KB, Gates S, Beebe RT.
    Arch Intern Med; 1966 Dec; 118(6):565-71. PubMed ID: 5925444
    [No Abstract] [Full Text] [Related]

  • 8. Value of urinary hydroxyproline and bone isoenzyme of alkaline phosphatase in the early detection and follow-up of bone metastasis in breast cancer patients.
    Frenay M, Namer M, Boublil JL, Khater R, Viot M, François E, Milano G.
    Bull Cancer; 1988 Dec; 75(6):533-9. PubMed ID: 3416085
    [Abstract] [Full Text] [Related]

  • 9. [Collagen metabolism in hyperthyroidism].
    Rommel K, Fourie L, Böhm W, Adam WE, Benecke G.
    Med Klin; 1968 Mar 15; 63(11):410-3. PubMed ID: 4177533
    [No Abstract] [Full Text] [Related]

  • 10. [Plasma free amino acids in malignant bone tumors and in healthy subjects].
    Zender R, Courvoisier B.
    Clin Chim Acta; 1970 Feb 15; 27(2):259-65. PubMed ID: 5417227
    [No Abstract] [Full Text] [Related]

  • 11. Urinary hydroxyproline and plasma mucoprotein as an indication of the presence of bone metastases.
    Basu TK, Donaldson D, Williams DC.
    Oncology; 1974 Feb 15; 30(3):197-203. PubMed ID: 4459734
    [No Abstract] [Full Text] [Related]

  • 12. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
    Francini G, Gonnelli S, Petrioli R, Bruni S, Marsili S, Aquino A, Camporeale A.
    Cancer Epidemiol Biomarkers Prev; 1993 Feb 15; 2(2):125-9. PubMed ID: 8467247
    [Abstract] [Full Text] [Related]

  • 13. Urinary hydroxyproline excretion in patients with cancer.
    Guzzo CE, Pachas WN, Pinals RS, Krant MJ.
    Cancer; 1969 Aug 15; 24(2):382-7. PubMed ID: 5796782
    [No Abstract] [Full Text] [Related]

  • 14. [The clinical significance of urinary hydroxyproline determinations (author's transl)].
    Raab W.
    Z Klin Chem Klin Biochem; 1972 May 15; 10(5):195-206. PubMed ID: 4219249
    [No Abstract] [Full Text] [Related]

  • 15. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
    Ditzel J, Jordal R, Riskaer N.
    Acta Endocrinol (Copenh); 1968 Nov 15; 59(3):353-61. PubMed ID: 5754976
    [No Abstract] [Full Text] [Related]

  • 16. [Urinary hydroxyproline excretion in generalized bone diseases].
    Czitober H, Raab W.
    Wien Z Inn Med; 1967 Nov 15; 48(10):401-8. PubMed ID: 5620579
    [No Abstract] [Full Text] [Related]

  • 17. [Diagnostic significance of the level of hydroxyproline excretion in myeloma multiplex].
    Radom S, Wieraszko-Burzyńska E, Zulawski M.
    Nowotwory; 1969 Nov 15; 19(3):173-80. PubMed ID: 5370331
    [No Abstract] [Full Text] [Related]

  • 18. [Urinary hydroxyproline in collagen diseases].
    Contreras V, Litvak J, Wortsman J, Michaud P, Armendaris R, Rojas A.
    Rev Med Chil; 1967 Jul 15; 95(7):352-5. PubMed ID: 4157382
    [No Abstract] [Full Text] [Related]

  • 19. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
    Cuschieri A.
    Br J Surg; 1973 Oct 15; 60(10):800-3. PubMed ID: 4748385
    [No Abstract] [Full Text] [Related]

  • 20. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
    Gasser AB, Depierre D, Alberto P, Courvoisier B.
    Schweiz Med Wochenschr; 1977 Jul 16; 107(28):984-6. PubMed ID: 897640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.